Drug Patents owned by Titan Pharms
1. List of Probuphine drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7736665 | TITAN PHARMS | Implantable polymeric device for sustained release of buprenorphine |
Apr, 2024
(1 year, 2 months from now) | |
Drugs and Companies using BUPRENORPHINE HYDROCHLORIDE ingredient
Market Authorisation Date: 26 May, 2016
Treatment: For opioid dependence
Dosage: IMPLANT;IMPLANTATION
More Information on Dosage
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic